66

Will Anyone be Spared Damage from mRNA?

Dr. McCullough on ZEEE Media with an Update
66

By Peter A. McCullough, MD, MPH

You can tell by the look on her face that media mogul Maria Zeee from Melbourne is increasingly concerned about emerging serious medical events two years after the primary series of mRNA injections in 2020-21. On that list of problems includes cardiac arrest, heart arrhythmias, acceleration of atherosclerotic cardiovascular disease, stroke, Guillain Barre Syndrome, persistent small fiber neuropathy, existing and new large blood clots in the extremities, and auto-immune problems.

Many regret taking the shots and feel if they can get past the initial concerns, they can put this nightmare behind them. The largest residual concern is cancer. For oncogenic risks with novel genetic therapies such as Pfizer, Moderna, Janssen, and AstraZeneca COVID-19 vaccines, the risk timeline is typically five years for the recurrence from remission or de novo occurrence of cancer.

The good news is that Schmeling et al have shown that about one third of vaccine recipients have zero side effects and in my experience this tends to remain the case during the period of time we have for observation thus far. Conversely, only 4.2% of doses appeared to be high risk (see lot numbers) and these occurred in early batches.

Schmeling M, Manniche V, Hansen PR. Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. Eur J Clin Invest. 2023 Aug;53(8):e13998. doi: 10.1111/eci.13998. Epub 2023 Apr 9. PMID: 36997290.

Please list to this segment shot on November 11, 2023, interview for key citations and updates on mRNA threatening the food supply and answers coming from Australian suppliers.

Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.

Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Peter A. McCullough, MD, MPH

President, McCullough Foundation

www.mcculloughfnd.org

Many thanks for these kind words.  We have more work to do.  Please share to support:  www.mcculloughfnd.org

Schmeling M, Manniche V, Hansen PR. Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. Eur J Clin Invest. 2023 Aug;53(8):e13998. doi: 10.1111/eci.13998. Epub 2023 Apr 9. PMID: 36997290.

66 Comments